Search PubMed⌕ Search

Biomedical subjects

D Green

Publications and source records attributed to D Green.

At least 469 records · Page 26Linked to original sources

Radiation dose from plutonium deposited in marrow and bone of normal and chimaeric mice.

239Pu citrate was injected intraperitoneally into CBA mice and into CBA mice which had been made chimaeric by replacing their haematopoietic bone-marrow with that from another genetically-identical but cytologically-distinct strain. The mice were killed at three intervals up to 90 days after injection, and the deposited 239Pu was determined radiochemically in bone-marrow and in bone. The average radiation dose (integrated over 90 days) was found to be greater in the bones but lower in the marrow of chimaeric mice than in the corresponding tissues of the normal CBA mice. These results are discussed from the points of view of induction of malignant change in marrow and bone and of plutonium metabolism in the two types of mouse.

Animals↗

Some factors affecting fibrinogen precipitation by ristocetin: ultrastructure of precipitates.

Fibrinogen in aqueous solution is precipitated by the antibiotic ristocetin. This reaction is inhibited by albumin and facilitated by low temperature. Resolubilized fibrinogen clots in the presence of thrombin. Ristocetin-precipitated fibrinogen takes the form of fibrils or clumps, composed of irregularly spaced, structure-less particles. The addition of ristocetin to washed platelets suspended in fibrinogen-containing media produces fibrinogen clumps in both the media and in the surface cannalicular system of the platelets. The changes in light transmission (aggregation curves) are due to both platelet aggregation and fibrinogen clumping. The role of the latter is confirmed by the observation that the addition of ristocetin to inert latex particles suspended in fibrinogen solution produces typical aggregation curves. This phenomenon is prevented by the addition of albumin to the media. We conclude that (1) if fibrinogen is present in any artificial system, albumin should be included in the media to prevent fibrinogen precipitation; and (2) statements about aggregation of any particulated materials by ristocetin should not be based solely on light-transmission changes, but should also include a description of the morphologic appearance.

Blood Platelets↗

Single donor, HL-A matched platelet transfusions for thrombocytopenic patients undergoing surgery.

Thrombocytopenic patients, who displayed hemostatic disorders and had been previously sensitized by repeated blood transfusions and/or pregnancies, were supported for surgical procedures by platelet transfusions obtained from a single ABO and HL-A matched donor by the use of continuous collection centrifugation. Because of the low incidence of HL-A identical donors, compatibility was assessed by known serological cross-reactivity of the HL-A determinants. In three cases repeated platelet transfusions had excellent in vivo survival, and sensitization could not be detected by a battery of immunological assays. In one case there was immune sensitization and refractoriness to repeated platelet transfusion, as documented by accelerated in vivo destruction of donor and third-party platelets bearing the disparate factor HL-A8. Although serologic tests for lymphocytotoxic and leukoagglutinating antibodies were negative, the patient displayed cellular immunity in leukocyte aggregation and cell-mediated plateletolysis tests. The single donor, continuous collection technique appears to have the technical advantage of rapid, efficient collection and the immunological benefit of a restricted spectrum of allosensitization.

ABO Blood-Group System↗